Responsible Institution: China Association for Science and Technology
Sponsored by: The Chinese Pharmacological Society
Editor-in-Chief: HUANG Zhili
ISSN 1009-2501
CN 34-1206/R
Explore on the effects of General Friedman's Urn Model on power in clinical trial through simulation experiments
YU Li-li1, BU Xiao-dong2, GU Xin1, DU Qian1, XIA Jie-lai3
1Department of Information Technology 2Department of Science Research and Training, the General Hospital of Jinan Military Command, Jinan 250031, Shandong, China 3Department of Health Statistics, Faculty of Preventative Medicine, the Fourth Military Medical University, Xi'an 710032, Shaanxi, China
YU Li-li, BU Xiao-dong, GU Xin, DU Qian, XIA Jie-lai. Explore on the effects of General Friedman's Urn Model on power in clinical trial through simulation experiments[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(3): 286-289.
[1] Athreya KB,Karlin S. Embedding of urn schemes into continuous time Markov branching processes and related limit theorems[J]. Ann Math Stat,1968, 39:1801-1807. [2] 于莉莉,夏结来. 临床试验适应性设计的随机化方法简介 --反应变量-自适应随机化[J]. 中国卫生统计,2008, 25(5) :534-537. [3] Wei LJ. The generalized Polya's urn design for sequential medical trials[J]. Ann Statist,1979,7: 291-296. [4] Rosenberger WF, Lachin JM. Randomization in clinical trials: Theory and practice[M]. New York, Wiley. 2002. [5] 于莉莉,李霞,步晓冬,等.临床试验中访视时间与入组速度对瓮模型组间分配比例的影响[J].中国临床药理学与治疗学,2011,16(5):506-509. [6] CR Palmer, WF Rosenberger .Ethics and Practice: Alternative designs for phase Ⅲ randomized clinical trials[J]. Controlled Clinical Trials,1999, 20: 172-186.